Abstract #4591

Are Dynamic First-Pass Enhancement Properties of Gadoxetic Acid (Gd-EOB-DTPA) Comparable to Gadopentetate Dimeglumine (Gd-DTPA) in Hepatocellular Carcinoma (HCC)?

Mi-Suk Park¹, Myeong-Jin Kim², Ki Whang Kim¹

¹Department of Diagnostic Radiology, Yonsei University Health System Severance Hospital, Seoul, Korea, Republic of; ²Severance hospital

In this abstract, we compared dynamic first-pass enhancement properties of gadoxetic acid with that of gadopentetate dimeglumine in the patients with HCC. Gadoxetic acid-enhanced MRI showed more rapid wash-out of HCC, stronger enhancement of hepatic parenchyma, and weaker enhancement of vessels than the standard Gd-chelate enhanced MRI.